The prevalence and prognostic value of CD168 in early-stage oral squamous cell carcinoma
Our results demonstrate a significant proportion of CD168-positive tumors in OSCC and suggest an impact on prognosis, particularly with regard to OS.
Authors
- Christian Doll (ORCID: https://orcid.org/0000-0002-0439-759X)
- Konrad Neumann (ORCID: https://orcid.org/0000-0001-9482-0971)
- Friedrich Mrosk (ORCID: https://orcid.org/0000-0002-6956-3843)
- Jan-Dirk Raguse
- Korinna Jöhrens (ORCID: https://orcid.org/0000-0001-5934-544X)
- Elena Hofmann (ORCID: https://orcid.org/0000-0003-4458-9278)
- Steffen Koerdt (ORCID: https://orcid.org/0000-0002-8679-8775)
- Max Heiland (ORCID: https://orcid.org/0000-0002-4987-2913)
- Maximilian Richter (ORCID: https://orcid.org/0000-0002-7305-4224)
- Anna Reds
Institutions
- Humboldt-Universität zu Berlin (DE)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Fachklinik Hornheide (DE)
- Klinikum Chemnitz (DE)
Publication Details
- Journal
- Oral Oncology
- Published
- 2025-04-27
- DOI
- https://doi.org/10.1016/j.oraloncology.2025.107329
- Citations
- 1
- Primary Topic
- Proteoglycans and glycosaminoglycans research
- Type
- article
- Field-Weighted Citation Impact
- 1.15